HEMA Flashcards
Removes produced fibrins
plasmin
Cancer of blood
Leukemia
mimics the laboratory results of leukemia
Leukomoid reaction
High WBC count (↑ >50,000 ul)
INCREASE LAP
LEFT SHIFT ( young or blast cells instead of mature cells) PRESENCE OF DOHLE BODIES AND TOXIC GRANULES
ABSENCE OF AUER RODS AND PHILADELPHIA CHROMOSOME
Leukomoid reaction
A form of malignancy in blood (due to lifestyle or genetic)
CHRONIC MYELOGENOUS LEUKEMIA
High WBC count (malignant cells)
✓ DECREASE LAP
✓ LEFT SHIFT
✓ PRESENCE OF AUER BODIES
✓ PRESENCE OF PHILADELPHIA CHROMOSOME
CHRONIC MYELOGENOUS LEUKEMIA
Bone marrow test:
abnormal presence of
higher than normal number of immature cells
Leukemia
Bone marrow test:
normal number of
immature cells
Leukomoid reaction
Lymph node biopsy test:
abnormal presence of immature cells
Leukemia
Lymph node biopsy:
normal mature cells are present
Leukomoid reaction
NEUTROPHIL OR
LEUKOCYTE PHOSPHATASE TEST:
High score
Leukomoid reaction
Test: NEUTROPHIL OR
LEUKOCYTE PHOSPHATASE (low score)
Leukemia
enzyme produced by young granulocytes; seen in neutrophils from the metamyelocyte to segmented stage
Alkaline phosphatase
clonal proliferations of malignant leukocytes that arise initially in the bone marrow before disseminating to the peripheral blood, lymph nodes, and other organs
Leukemia
second line of defense
WBCs
first to recognize leukemia as a distinct clinical disorder between 1839 and 1845.
Virchow
Major symptoms of leukemia
fever, weight loss, and increased sweating
symptoms occurring more predominantly in chronic leukemias.
Enlargement of the liver, spleen and lymph nodes
General term for malignancy that starts in the lymph system, mainly the lymph nodes
Lymphoma
form of cancer of the plasma cells.
myeloma
Duration of acute leukemia
days to 6 months
Duration of subacute leukemia:
2-6 months
Duration of chronic leukemia
1 or 2 years or more
PBS: WBC ct. <15,000 cells/ul, no immature or abnormal WBC
ALEUKEMIC LEUKEMIA
PBS: WBC ct. < 15,000 cells/ul, with immature or abnormal WBC
Sub leukemic leukemia
PBS: WBC ct. >15,000 cells/ul, with immature and
abnormal form
Leukemic leukemia
TYPES OF WBC INVOLVED:
Leukemia with predominance of immature (blast) WBC
Acute leukemia
TYPES OF WBC INVOLVED:
predominance of mature/old WBC
chronic leukemia
Primarily a disease of childhood or adolescence, accounting for 25% of childhood cancers and up to 75% of childhood leukemia
Acute Lymphoblastic Leukemia
affected cells in common ALL
Early pre-B cell
represents only about 15% of pediatric ALL cases while 25% of adult cases
associated with large mass in the mediastinum (10-20%)
T-cell ALL
HALLMARK: Auer rods
Acute Myeloid Leukemia (AML)
most common leukemia in adults, and the incidence increases with age
Acute Myeloid Leukemia (AML)
Common abnormalities of AML
hyperuricemia, electrolytes (calcium, potassium, phosphate)
CELL MARKER: smudge cell
Chronic Lymphocytic Leukemia
Majority of cases of CLL appears to involve —- lymphocytes
B lymphocytes
Clinical signs are lymphadenopathy, fatigue, weight loss, splenomegaly, and hepatomegaly
Chronic Lymphocytic Leukemia (CLL)
bone marrow and peripheral blood films show small lymphoid cells with a characteristically coarse chromatin (“soccer-ball” pattern), absent or inconspicuous nucleoli, and scant cytoplasm
Chronic Lymphocytic Leukemia (CLL)
HALLMARK: Philadelphia chromosomes
Chronic Myelogenous Leukemia (CML)
Transfer of long arm of chromosome 22 to 9
Chronic Myelogenous Leukemia (CML)
All cases of CML are POSITIVE (+) for gene
BCR-ABL1
A myeloproliferative disorder characterized by pancytosis
Chronic Myelogenous Leukemia (CML)
90% of cases are positive for Philadelphia chromosome t(9:22)
Chronic Myelogenous Leukemia (CML)
Chemicals predisposing factors for developing leukemia and lymphoma
Benzene, Hydrocarbons, hair dyes (organic
materials)
Environmental predisposing factors for developing leukemia and lymphoma
Ionizing radiation, insecticides, herbicides, and
fungicides
Drugs predisposing factors for developing leukemia and lymphoma
Alkylating agents, chloramphenicol
Viruses predisposing factors for developing leukemia and lymphoma
EBV, HIV, HTLV
Genetic syndrome predisposing factors for developing leukemia and lymphoma
Down syndrome, Fanconi anemia
Classified acute leukemia as presence of ≥30% blast in the peripheral blood and bone marrow
French American British (FAB)
FAB - SUBDIVIDE LEUKEMIA ACCORDING TO:
- Cellular morphology
- Cytochemical staining results.
Widely used to classify leukemia. It is now the standard classification in diagnosing leukemia
World Health Organization
defines acute leukemia as ≥ 20% peripheral blood and bone marrow blasts
World Health Organization
WHO - SUBDIVIDE LEUKEMIA ACCORDING TO:
- Cellular morphology
- Cytochemical stains(cytochemistry)
- Immunophenotyping (Flow cytometry)
- Cytogenetics abnormalities
- Clinical syndrome
Devoted to the laboratory study of visible chromosome abnormalities, such as deletions, translocations, and aneuploidy
Cytogenetic Analysis (Karyotyping)
Use of specialized stains to detect cellular enzymes and other chemicals in peripheral blood films and bone marrow aspirate smears. Used to differentiate hematologic diseases, especially leukemias.
Cytochemistry
Used to identify cells on the basis of the types of markers or antigens present on the cell’s surface, nucleus, or cytoplasm
IMMUNOPHENO TYPING (FLOW CYTOMETRY)
Anemia caused by bleeding and replacement of normal marrow elements by leukemic blasts
Acute Leukemias
Peripheral blood and bone marrow smear: more immature cells and blast cells
Acute Leukemias
ACUTE MYELOID LEKUEMIA (AML) is also called
Acute Myelogenous Leukemia; Acute Non-Lymphocytic Leukemia
WHO classification of AML not otherwise categorized; Undifferentiated blasts, AML— not otherwise categorized
Minimal differentiation
M0 (Myeloid)
Blasts and promyelocytes predominate without further maturation of myeloid cells
In other cases, the blasts resemble LYMPHOBLASTS, from which they
are differentiated by positivity to myeloperoxidase stains or Sudan black in
at least 3% of blast cells
M1 (myeloid)/ acute myeloblastic leukemia without maturation
demonstrate maturation beyond the blast and promyelocyte stage
Blasts may show azurophilic granules and Auer rods, and evidence of maturation is present
M2 (myeloid)/ acute myeloblastic leukemia with maturation.
Promyelocytes predominate in the bone marrow; DIC - most common cause of death
Highest number of Auer rods, collectively named as Faggot cells/Firewood
cells seen in bundles
M3 (promyelomonocytic)
AML associated with chromosomal translocation of 15:17
M3 (promyelomonocytic)
Monoblasts are large cells with round containing one or more prominent nuclei and abundant basophilic cytoplasm, sometimes with fine azurophilic granules, vacuoles, and PSEUDOPOD FORMATION
referred to as Naegeli type monocytic leukemia
acute myelomonocytic leukemia (M4)
AML characterized by large blasts in bone marrow and peripheral blood (common in young adults)
FAB M5a/ acute monoblastic leukemia
AML differentiated type by monoblasts, promonocytes, and monocytes (common during middle age)
FAB M5b/acute monocytic leukemia
SCHILLING’S TYPE leukemia WHO classification
Acute monoblastic and acute monocytic leukemia (M5a, M5b)
Abnormal proliferation of both erythroid and granulocytic precursors; may include abnormal megakaryocytic and monocytic proliferations
Erythroleukemia/Erythemic Myelosis or Di Guglielmo syndrome
Large and small megakaryoblasts with a high nuclear cytoplasmic ratio; pale, agranular cytoplasm
Dysplastic platelets may be visible in the blood, as may be circulating micromegakaryocytes and megakaryocyte fragments
M7 (megakaryocytic)/acute megakaryoblastic leukemia
Constitute 5% of AML
✓ At least 50% of the nucleated cells in the bone marrow is are erythroid
✓ At least of 20% of nonerythroid cells are myeloblast – the myeloblast are
similar to those in AML with and without maturation (M1 and M2)
Acute erythroid leukemia (M6a)
✓ Cases are very rare
✓ >80% of the marrow cells are erythroid
✓ The erythroblast has deeply basophilic, often agranular, cytoplasm that
may contain poorly delineated vacuoles
✓ The round nuclei have fine chromatin and one or more nuclei
M6(b): Pure Erythroid Leukemia
Positive control for MPO staining
AML minimally differentiated
mature granulocyte
Positive control for MPO staining in AML without maturation
Myelocyte
Classification of AML in four general groups according to WHO
- AML not otherwise categorized
- AML with recurrent genetic abnormalities
- AML with multilineage dysplasia
- AML and myelodsplastic syndromes, therapy-related
✓ 5%-10% of AML cases
✓ Predominantly younger patients
✓ Blasts – typically large, with abundant basophilic cytoplasm, often with
Auer rods and numerous, sometimes very large azurophilic granules
AML with t(8;21) (q22;q22)
✓ 10% of AML cases
✓ Primarily in younger patients
✓ The bone marrow usually has elements of both granulocytic and
monocytic differentiation combined with abnormal eosinophils
✓ M4eo in FAB classification or acute myelomonocytic leukemia with
abnormal eosinophils
✓ Eosinophil precursors contain abnormally large purple granules that can
be sufficiently numerous to obscure the nuclei
AML with inv (16) (p13q22) or t(16;16) (p13;q22)
✓ 5% of AML
✓ Acute promyelocytic leukemia
✓ Abnormal promyelocytes are present, either hypergranular or
hypogranular (microgranular)
✓ M3 or M3v in FAB classification
✓ In the hypergranular form, the cytoplasm is packed with pink, red, or
purple granules that are usually large, but may be fine.
✓ Bundles of Auer rods are present in most cases; the nuclei, which may be
bilobed, are irregular in size and variable in shape and maybe reniform
(kidney-shaped)
AML with t(15;17) (q22;q12) or acute promyelocytic leukemia
✓ 5% of AML cases
✓ Occurs at any age,but more common among children
✓ Monocytic differentiation, with monoblasts and promonocytes
predominating, is the most common morphologic pattern
✓ Patients may have gum infiltration, and DIC
✓ Monoblasts are large cells with round nuclei that usually contain lacy
chromatin and large prominent nucleoli
✓ The abundant basophilic and sometimes vacuolated cytoplasm may form
pseudopods and contain scattered, fine azurophilic granules.
AML with 11q23 abnormalities
Abnormal erythropoiesis is characterized by ringed sideroblasts, vacuolated cytoplasm, and nuclei that are multiple, fragmented, or megaloblastic
AML with multilineage dysplasia
Abnormal megakaryocytes are small or have single-lobed or multiple, discrete
nuclei
AML with multilineage dysplasia
AML and myelodsplastic syndromes, therapy-related occurs after theraphy with
topoisomerase II inhibitors (etoposide and doxorubicin)
3 stages of CML according to WHO
- Chronic phase (CML-CP )
- Accelerated phase (CML-AP )
- Blast phase (CML-BP )
CML PHASE: Basophils are universally increased
Eosinophilia is common
Serum LDH and uric acid - increased
Chronic Phase